Literature DB >> 22450977

Class A carbapenemase FPH-1 from Francisella philomiragia.

Marta Toth1, Viktoria Vakulenko, Nuno T Antunes, Hilary Frase, Sergei B Vakulenko.   

Abstract

FPH-1 is a new class A carbapenemase from Francisella philomiragia. It produces high-level resistance to penicillins and the narrow-spectrum cephalosporin cephalothin and hydrolyzes these β-lactam antibiotics with catalytic efficiencies of 10(6) to 10(7) M(-1) s(-1). When expressed in Escherichia coli, the enzyme confers resistance to clavulanic acid, tazobactam, and sulbactam and has K(i) values of 7.5, 4, and 220 μM, respectively, against these inhibitors. FPH-1 increases the MIC of the monobactam aztreonam 256-fold and the MIC of the broad-spectrum cephalosporin ceftazidime 128-fold, while the MIC of cefoxitin remains unchanged. MICs of the carbapenem antibiotics imipenem, meropenem, doripenem, and ertapenem are elevated 8-, 8-, 16-, and 64-fold, respectively, against an E. coli JM83 strain producing the FPH-1 carbapenemase. The catalytic efficiencies of the enzyme against carbapenems are in the range of 10(4) to 10(5) M(-1) s(-1). FPH-1 is 77% identical to the FTU-1 β-lactamase from Francisella tularensis and has low amino acid sequence identity with other class A β-lactamases. Together with FTU-1, FPH-1 constitutes a new branch of the prolific and ever-expanding class A β-lactamase tree.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22450977      PMCID: PMC3370778          DOI: 10.1128/AAC.00223-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.

Authors:  E B Chaïbi; D Sirot; G Paul; R Labia
Journal:  J Antimicrob Chemother       Date:  1999-04       Impact factor: 5.790

Review 2.  Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity.

Authors:  Jed F Fisher; Samy O Meroueh; Shahriar Mobashery
Journal:  Chem Rev       Date:  2005-02       Impact factor: 60.622

3.  SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.

Authors:  Anne Marie Queenan; Wenchi Shang; Paul Schreckenberger; Karen Lolans; Karen Bush; John Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

Review 4.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

5.  Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae.

Authors:  B A Rasmussen; K Bush; D Keeney; Y Yang; R Hare; C O'Gara; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 6.  Extended-spectrum beta-lactamase-producing organisms.

Authors:  M E Falagas; D E Karageorgopoulos
Journal:  J Hosp Infect       Date:  2009-07-10       Impact factor: 3.926

7.  Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.

Authors:  Fátima Fonseca; Ana Cristina Sarmento; Isabel Henriques; Bart Samyn; Jozef van Beeumen; Pedro Domingues; Maria Rosário Domingues; Maria José Saavedra; António Correia
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

8.  Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

9.  Genetic and biochemical characterization of GES-5, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.

Authors:  Il Kwon Bae; You-Nae Lee; Seok Hoon Jeong; Seong Geun Hong; Jung Hun Lee; Sang Hee Lee; Hyoung Jin Kim; Hasik Youn
Journal:  Diagn Microbiol Infect Dis       Date:  2007-04-27       Impact factor: 2.803

10.  Mechanistic basis for the emergence of catalytic competence against carbapenem antibiotics by the GES family of beta-lactamases.

Authors:  Hilary Frase; Qicun Shi; Sebastian A Testero; Shahriar Mobashery; Sergei B Vakulenko
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

View more
  9 in total

Review 1.  A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Authors:  Alain Philippon; Patrick Slama; Paul Dény; Roger Labia
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

2.  Antibiotic resistance and substrate profiles of the class A carbapenemase KPC-6.

Authors:  Toni L Lamoureaux; Hilary Frase; Nuno T Antunes; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

3.  A novel extended-spectrum β-lactamase, SGM-1, from an environmental isolate of Sphingobium sp.

Authors:  Toni L Lamoureaux; Viktoria Vakulenko; Marta Toth; Hilary Frase; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

Review 4.  Structural and Functional Aspects of Class A Carbapenemases.

Authors:  Thierry Naas; Laurent Dortet; Bogdan I Iorga
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

Review 5.  Genetic Determinants of Antibiotic Resistance in Francisella.

Authors:  Stephen J Kassinger; Monique L van Hoek
Journal:  Front Microbiol       Date:  2021-05-12       Impact factor: 5.640

6.  Francisella sp., a Close Relative of Francisella orientalis, Causing Septicemia with Cholestatic Hepatitis in a Patient with Anti-Interferon-γ (IFN-γ) Autoantibodies.

Authors:  Rattagan Kajeekul; Somchai Insiripong; Athita Riwlord; Suleeporn Poomchuchit; Anusak Kerdsin
Journal:  Trop Med Infect Dis       Date:  2022-02-11

7.  Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-β-lactamases.

Authors:  Maria F Mojica; S Graciela Mahler; Christopher R Bethel; Magdalena A Taracila; Magda Kosmopoulou; Krisztina M Papp-Wallace; Leticia I Llarrull; Brigid M Wilson; Steven H Marshall; Christopher J Wallace; Maria V Villegas; Michael E Harris; Alejandro J Vila; James Spencer; Robert A Bonomo
Journal:  Biochemistry       Date:  2015-05-12       Impact factor: 3.162

8.  Structural and Biochemical Characterization of Rm3, a Subclass B3 Metallo-β-Lactamase Identified from a Functional Metagenomic Study.

Authors:  Ramya Salimraj; Lihong Zhang; Philip Hinchliffe; Elizabeth M H Wellington; Jürgen Brem; Christopher J Schofield; William H Gaze; James Spencer
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

9.  Potency of Vaborbactam Is Less Affected than That of Avibactam in Strains Producing KPC-2 Mutations That Confer Resistance to Ceftazidime-Avibactam.

Authors:  Ruslan Tsivkovski; Olga Lomovskaya
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.